The Discounted Cash Flow (DCF) valuation of Neurocrine Biosciences Inc (NBIX) is 157.52 USD. With the latest stock price at 142.73 USD, the upside of Neurocrine Biosciences Inc based on DCF is 10.4%.
Based on the latest price of 142.73 USD and our DCF valuation, Neurocrine Biosciences Inc (NBIX) is a buy. buying NBIX stocks now will result in a potential gain of 10.4%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 7.8% | 7.0% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 109.67 - 297.68 | 157.52 |
| Upside | -23.2% - 108.6% | 10.4% |